Treatment of eye disorders characterized by an elevated introacular pressure by siRNAs

Details for Australian Patent Application No. 2005276245 (hide)

Owner Sylentis S.A.U

Inventors Jimenez, Ana I.; Roman, Jose P.; Gascon, Irene; Gonzalez De Buitrago, Gonzalo; Sesto, Angela

Agent Griffith Hack

Pub. Number AU-B-2005276245

PCT Pub. Number WO2006/021817

Priority 0418762.1 23.08.04 GB; 0503412.9 18.02.05 GB

Filing date 23 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 3 June 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/021817 Priority application(s): WO2006/021817

3 June 2010 Application Accepted

  Published as AU-B-2005276245

16 September 2010 Opposition Lodged

  Alcon Research, Ltd. has lodged an opposition against Sylentis S.A.U.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005276249-A cartridge reactor for a flow-type laboratory hydrogenation apparatus

2005276242-Medicament